Table 3. Adverse events at 1-year follow-up visit.
| Outcomes | Remote patient management (n=1040) | Usual care (n=1046) | P value |
|---|---|---|---|
| MACCEa, n (%) | 36 (3.5) | 55 (5.3) | .04 |
| Cardiac death | 10 (1.0) | 24 (2.3) | .02 |
| Myocardial infarction | 8 (0.8) | 19 (1.8) | .03 |
| Target vessel revascularization | 14 (1.4) | 17 (1.7) | .59 |
| Stroke | 10 (1.0) | 14 (1.4) | .41 |
| All-cause mortality, n (%) | 19 (1.8) | 29 (2.8) | .15 |
| Non-Cardiac death, n (%) | 9 (0.9) | 5 (0.5) | .29 |
| First unplanned heart failure or angina hospitalization, n (%) | 61 (5.9) | 66 (6.4) | .65 |
| Stent thrombosis, n (%) | 3 (0.3) | 5 (0.5) | .48 |
| Any bleeding, n (%) | 96 (9.3) | 92 (8.9) | .68 |
| BARCb1 | 54 (5.2) | 54 (5.2) | .95 |
| BARCb2 | 36 (3.5) | 22 (2.1) | .06 |
| BARCb3-5 | 6 (0.6) | 16 (1.6) | .03 |
a
MACCE: major adverse cardiac and cerebrovascular events.
b
BARC: Bleeding Academic Research Consortium.